<sup>18</sup>F-氟代脱氧葡萄糖PET在鼻咽癌中的临床应用价值

张雯杰; 郑容; 吴宁

¹⁸F-氟代脱氧葡萄糖PET在鼻咽癌中的临床应用价值

张雯杰 , 郑容 , 吴宁

文章导航 > 国际放射医学核医学杂志 > 2006, 30 > 2: (94-97)

引用本文:

Citation:

¹⁸F-氟代脱氧葡萄糖PET在鼻咽癌中的临床应用价值

1. 100021 北京, 中国医学科学院、中国协和医科大学肿瘤医院核医学科;
2. 100021 北京, 中国医学科学院、中国协和医科大学肿瘤医院放射诊断科
中图分类号: R817.4

Application of ¹⁸F-fluorodeoxyglucose PET in nasopharyngeal carcinoma

1. Department of Nuclear Medicine, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;
2. Department, of Radiology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
CLC number: R817.4

摘要: ¹⁸F-FDG PET作为一种功能显像技术,通过一次性全身显像,可以检出常规影像学检查阴性的隐匿病灶,对于鼻咽癌颈部淋巴结转移、远处转移有较高的临床价值,对于疗效监测、早期检测残存或肿瘤复发方面也优于传统的影像学方法。但PET对局部组织结构分辨能力远不如CT和MRI,PET-CT则通过解剖和功能图像的融合技术克服了这一缺陷。
- 鼻咽肿瘤 /
- 体层摄影术,发射型计算机 /
- ¹⁸F-氟脱氰葡萄糖
Abstract: 18F-fluorodeoxyglueose (¹⁸F-FDG) PET is a king of functional imaging technique. It can reveal occult distant melastases on routine imaging. It has a significant clinical impact on detecting cervical nodal involvement, distant metastasis. ¹⁸F-FDC PET is also superior to conventional anatomic imaging modalities in monitoring curative effect and differentiating recurrent or residual disease from therapy-induced changes in nasopharyngeal carcinoma. Compared with CT and MRI, the inherent limitation of ¹⁸F-FDG PET is poor anatomic resolution. Combined PET and CT (PET-CT) can often overcome these difficulties by fusing anatomic and physiological data.
- Nasopharyngeal neoplasms /
- Tomography,emission-computed /
- ¹⁸F-fluorodeoxyglucose
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Mitsuhashi N,Hayakawa K,Hasegawa M,et al.Clinical FDG-PET in diagnosis and evaluation of radiation response of patients with nasopharyngeal tumor.Anticancer Res,1998,18(4B):2827-2832.
[2]	Kao CH,Hsieh JF,Tsai SC,et al.Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma.Ann Otol Rhinol Laryngol,2000,109(12 Pt 1):1130-1134.
[3]	Yen TC,Chang JT,Ng SH,et al.The value of ¹⁸F-FDG PET in the detection of stage MO carcinoma of the nasopharynx.J Nucl Med,2005,46(3):405-410.
[4]	Kao CH,Shiau YC,Shen YY,et al.Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography:comparison with 18-fluoro-2-deoxyglucose positron emission tomography.Cancer,2002,94(7):1981-1986.
[5]	Kao CH,Tsai SC,Wang JJ,et al.Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium-99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy.Cancer,2001,92(2):434-439.
[6]	Kao CH,ChangLai SP,Chieng PU,et al.Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography.J Clin Oncol,1998,16(11):3550-3555.
[7]	Tsai MH,Huang WS,Tsai JJ,et al.Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomography in patients with indeterminate computed tomography findings.Antieancer Res,2003,23(4):3513-3516.
[8]	Tsai MH,Shiau YC,Kao CH,et al.Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy.J Cancer Res Clin Oncol,2002,128(5):279-282.
[9]	Yen RF,Hung RL,Pan MH,et al.18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging.Cancer,2003,98(2):283-287.
[10]	Ng SH,Joseph CT,Chan SC,et al.Clinical usefulness of ¹⁸F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence.J Nucl Med,2004,45(10):1669-1676.
[11]	Liu SH,Chang JT,Ng SH,et al.False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient.Br J Radiol,2004,77(915):257-260.
[12]	余党凡, 左传涛, 戴嘉中, 等. FDG-PET/CT在鼻咽癌放疗后随访中的初步应用研究.癌症,英文版,2004,23(11 Suppl):1538-1541.

[1]	冼伟均 , 冯彦林 , 袁建伟 , 张宁 , 黄克敏 , 贺小红 , 袁白虹 , 苏少弟 , 刘艳 , 叶秋莲 . ¹⁸F-FDG PET-CT对裸鼠鼻咽癌移植瘤放疗疗效的早期评估及与Ki67表达的相关性研究. 国际放射医学核医学杂志, 2010, 34(1): 11-15. doi: 10.3760/cma.j.issn.1673-4114.2010.01.003
[2]	吕清湖 , 唐明灯 , 林端瑜 , 刘道佳 , 李生栩 . 原发鼻咽淋巴瘤与鼻咽癌的¹⁸F-FDG PET/CT诊断与鉴别. 国际放射医学核医学杂志, 2017, 41(3): 166-172. doi: 10.3760/cma.j.issn.1673-4114.2017.03.002
[3]	王颖 , 冯彦林 . ¹⁸F-FDG PET-CT在鼻咽癌靶区勾画及推量照射研究中的价值. 国际放射医学核医学杂志, 2011, 35(2): 84-88. doi: 10.3760/cma.j.issn.1673-4114.2011.02.005
[4]	田月丽 , 兰晓莉 , 张永学 . ¹⁸F-FDG PET/CT在鼻咽癌综合治疗后患者随访及预后评估中的价值. 国际放射医学核医学杂志, 2013, 37(6): 359-363,377. doi: 10.3760/cma.j.issn.1673-4114.2013.06.009
[5]	叶慧 , 莫逸 , 谢爱民 , 彭翔 . ¹⁸F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究. 国际放射医学核医学杂志, 2008, 32(3): 147-150.
[6]	黄喆敏 , 左传涛 , 管一晖 . ¹⁸F-氟脱氧葡萄糖的脑肿瘤PET. 国际放射医学核医学杂志, 2007, 31(3): 163-165,172.
[7]	邢岩 , 赵晋华 . ¹⁸F-氟脱氧葡萄糖PET及PET-CT早期诊断肿瘤复发. 国际放射医学核医学杂志, 2007, 31(6): 341-344.
[8]	李林法 . ¹⁸F-氟代脱氧葡萄糖正电子发射体层显像在感染与炎症病变中的应用. 国际放射医学核医学杂志, 2006, 30(1): 26-29.
[9]	彭添兴 , 吴华 . ¹⁸F-氟脱氧葡萄糖以外新型PET肿瘤显像剂. 国际放射医学核医学杂志, 2007, 31(1): 9-12.
[10]	吕慧清 , 张中民 , 吕仲虹 . ¹⁸F-氟代脱氧葡萄糖PET在恶性肿瘤适形放射治疗中的价值. 国际放射医学核医学杂志, 2006, 30(6): 335-337.

点击查看大图

计量

文章访问数: 1053
HTML全文浏览量: 73
PDF下载量: 2

¹⁸F-氟代脱氧葡萄糖PET在鼻咽癌中的临床应用价值

1. 100021 北京, 中国医学科学院、中国协和医科大学肿瘤医院核医学科;
2. 100021 北京, 中国医学科学院、中国协和医科大学肿瘤医院放射诊断科

收稿日期: 2005-01-31

关键词:

摘要: ¹⁸F-FDG PET作为一种功能显像技术,通过一次性全身显像,可以检出常规影像学检查阴性的隐匿病灶,对于鼻咽癌颈部淋巴结转移、远处转移有较高的临床价值,对于疗效监测、早期检测残存或肿瘤复发方面也优于传统的影像学方法。但PET对局部组织结构分辨能力远不如CT和MRI,PET-CT则通过解剖和功能图像的融合技术克服了这一缺陷。